<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04017728</url>
  </required_header>
  <id_info>
    <org_study_id>960HP20190051</org_study_id>
    <nct_id>NCT04017728</nct_id>
  </id_info>
  <brief_title>Percutaneous Vertebroplasty Using Rotary Cutter for Bone Metastases</brief_title>
  <official_title>Percutaneous Vertebroplasty Using Rotary Cutter for Treating Bone Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Li Min</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jinan Military General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous vertebroplasty has been applied widely to treat bone metastases. The injected
      cement may strengthen the affected bone to prevent pathological fractures and relieve the
      pain. Moreover, the thermal reaction (70Â°C) due to polymerisation of cement also contributes
      to tumour destruction. The cement dose and diffusion pattern may be significant factors for
      the treatment efficacy, which can be affected by the inner pressure of the metastases. The
      investigators will apply a rotary cutter to destroy the structure of metastases to alleviate
      the pressure in the metastases. Then, more cement will be injected, which may effectively
      interdigitates with the surrounding bone and generate more thermo to kill the tumor cells.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 30, 2019</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Back pain: Visual analogue scales system</measure>
    <time_frame>3 months</time_frame>
    <description>Measuring and comparing the pre- and post-operative back pain via Visual analogue scales (VAS) system with values from 0 to 10 (0 indicating no pain and 10 indicating the worst pain). Patients with a VAS score lower than 3 were classified as the effective group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The patterns of cement opacification</measure>
    <time_frame>during the procedure of vertebroplasty</time_frame>
    <description>The patterns of cement opacification were classified as solid patterns (cement forms a mass), trabecular patterns (cement spread along the fine bone trabeculae), and mixed patterns (cement forms a mass with spreading along the fine bone trabeculae).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cement leakage</measure>
    <time_frame>during the procedure of vertebroplasty</time_frame>
    <description>The presence or absence of cement leakage is assessed in the groups with and without rotary cutter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cement volume</measure>
    <time_frame>during the procedure of vertebroplasty</time_frame>
    <description>The injected cement volume were evaluated in the two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Metastasis</condition>
  <arm_group>
    <arm_group_label>Conventional Percutaneous Vertebroplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The cement is injected after the successful puncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous Vertebroplasty with Rotary Cutter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The rotary cutter is applied to destroy the metastatic lesion before coment injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional Percutaneous Vertebroplasty</intervention_name>
    <description>The cement is injected into the bone metastases directly.</description>
    <arm_group_label>Conventional Percutaneous Vertebroplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous Vertebroplasty with Rotary Cutter</intervention_name>
    <description>The rotary cutter is applied before the cement injection. Then, the cement is injected with lower pressure.</description>
    <arm_group_label>Percutaneous Vertebroplasty with Rotary Cutter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Imaging-proven and pathology-proven metastases

          2. Intractable pain with neurologic dysfunction

        Exclusion Criteria:

        1. Poor general condition without tolerance of surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Min Li, M.D.</last_name>
    <phone>13953176057</phone>
    <email>liminyingxiang@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>960 Hospital of PLA</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250031</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Li, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 13, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>July 13, 2019</last_update_submitted>
  <last_update_submitted_qc>July 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Jinan Military General Hospital</investigator_affiliation>
    <investigator_full_name>Li Min</investigator_full_name>
    <investigator_title>Vice Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

